proactiveinvestors.ca
proactiveinvestors.ca
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
0 reviews

RECENT ARTICLES

Sort by:
No Rating
Lancaster Resources granted approval for Alkali Flat lithium brine drill program

Lancaster Resources granted approval for Alkali Flat lithium brine drill program

  Delivra Health Brands CEO Gord Davey joined Steve Darling from Proactive to announce the financial and operating results for the three and nine months ended March 31, 2024. The company reported a total net revenue from continued operations of $8,792, reflecting a 36% increase compared to...

No Rating
Awalé Resources partner Newmont advances to Phase 2 of earn-in agreement for Odienné JV

Awalé Resources partner Newmont advances to Phase 2 of earn-in agreement for Odienné JV

Awale Resources Ltd (TSX-V:ARIC) CEO Andrew Chubb joins Proactive's Stephen Gunnion with an update on the drilling programme at the Odienné project in Côte d'Ivoire, highlighting a particularly remarkable drill hole at the Charger target as "nothing short of spectacular." Chubb said the drill...

No Rating
Awalé Resources is pursuing gold and copper in untapped Cote d’Ivoire

Awalé Resources is pursuing gold and copper in untapped Cote d’Ivoire

Awale Resources Ltd (TSX-V:ARIC) CEO Andrew Chubb joins Proactive's Stephen Gunnion with an update on the drilling programme at the Odienné project in Côte d'Ivoire, highlighting a particularly remarkable drill hole at the Charger target as "nothing short of spectacular." Chubb said the drill...

Jan 1
Share
Save
Review
No Rating
Atossa Therapeutics gives final dose in breast cancer prevention study

Atossa Therapeutics gives final dose in breast cancer prevention study

Atossa Therapeutics CEO Dr Steven Quay joined Steve Darling from Proactive to share news the company has been granted, by the U.S. Patent office, a new patent directed to enterically encapsulated Endoxifen compositions formulated as a suspension. These will include all liquid suspension...

May 15
Share
Save
Review
No Rating
Atossa Therapeutics is developing innovative therapies to address unmet needs in breast cancer

Atossa Therapeutics is developing innovative therapies to address unmet needs in breast cancer

Atossa Therapeutics CEO Dr Steven Quay joined Steve Darling from Proactive to share news the company has been granted, by the U.S. Patent office, a new patent directed to enterically encapsulated Endoxifen compositions formulated as a suspension. These will include all liquid suspension...

June 21, 2023
Share
Save
Review
  • Total 5 items
  • 1
AUTHORS
Angela Harmantas

Angela Harmantas

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A
Emily Jarvie

Emily Jarvie

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A
Josh Lamb

Josh Lamb

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A
Proactive

Proactive

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A